Bleeding diathesis: Difference between revisions
Line 53: | Line 53: | ||
! rowspan="2" |Category | ! rowspan="2" |Category | ||
! rowspan="2" |Sub-category | ! rowspan="2" |Sub-category | ||
! rowspan="2" |Diseases | ! colspan="2" rowspan="2" |Diseases | ||
! rowspan="2" |History | ! rowspan="2" |History | ||
! colspan="5" |Clinical manifestation | ! colspan="5" |Clinical manifestation | ||
Line 72: | Line 72: | ||
| rowspan="13" |[[Platelet]] disorders | | rowspan="13" |[[Platelet]] disorders | ||
| rowspan="7" |[[Thrombocytopenia]] | | rowspan="7" |[[Thrombocytopenia]] | ||
|[[Infection]]-Induced Thrombocytopenia<span name="harr_c115s002s001s002p001"></span><span name="9100754"></span> | | colspan="2" |[[Infection]]-Induced Thrombocytopenia<span name="harr_c115s002s001s002p001"></span><span name="9100754"></span> | ||
| | | | ||
* History of prior infection | * History of prior infection | ||
Line 87: | Line 87: | ||
| | | | ||
|- | |- | ||
|[[Medication|Medications]]-Induced Thrombocy<span name="harr_c115s002s001s003p001"></span><span name="9100757"></span>topenia | | colspan="2" |[[Medication|Medications]]-Induced Thrombocy<span name="harr_c115s002s001s003p001"></span><span name="9100757"></span>topenia | ||
| | | | ||
* History of [[Medication|medications]] | * History of [[Medication|medications]] | ||
Line 102: | Line 102: | ||
| | | | ||
|- | |- | ||
|[[Heparin]]-Induced Thrombocytopenia<span name="harr_c115s002s001s004p001"></span><span name="9100761"></span> | | colspan="2" |[[Heparin]]-Induced Thrombocytopenia<span name="harr_c115s002s001s004p001"></span><span name="9100761"></span> | ||
| | | | ||
* [[Thrombosis]] | * [[Thrombosis]] | ||
Line 118: | Line 118: | ||
| | | | ||
|- | |- | ||
|[[Idiopathic thrombocytopenic purpura|Immune Thrombocytopenic Purpura]] ([[Idiopathic thrombocytopenic purpura|ITP]])<span name="harr_c115s002s001s005p001"></span><span name="9100771"></span> | | colspan="2" |[[Idiopathic thrombocytopenic purpura|Immune Thrombocytopenic Purpura]] ([[Idiopathic thrombocytopenic purpura|ITP]])<span name="harr_c115s002s001s005p001"></span><span name="9100771"></span> | ||
| | | | ||
* Prior [[infection]] or no history | * Prior [[infection]] or no history | ||
Line 133: | Line 133: | ||
| | | | ||
|- | |- | ||
|Inherited [[Thrombocytopenia]]<span name="harr_c115s002s001s006p001"></span><span name="9100783"></span> | | colspan="2" |Inherited [[Thrombocytopenia]]<span name="harr_c115s002s001s006p001"></span><span name="9100783"></span> | ||
| | | | ||
* Family history | * Family history | ||
Line 148: | Line 148: | ||
| | | | ||
|- | |- | ||
|[[Thrombotic thrombocytopenic purpura|Thrombotic Thrombocytopenic Purpura]] ([[Thrombotic thrombocytopenic purpura|TTP]])<span name="harr_c115s002s002s001p001"></span><span name="9100787"></span> | | colspan="2" |[[Thrombotic thrombocytopenic purpura|Thrombotic Thrombocytopenic Purpura]] ([[Thrombotic thrombocytopenic purpura|TTP]])<span name="harr_c115s002s002s001p001"></span><span name="9100787"></span> | ||
|History of: | |History of: | ||
*[[Cancer]] | *[[Cancer]] | ||
Line 169: | Line 169: | ||
| | | | ||
|- | |- | ||
|[[Hemolytic-uremic syndrome|Hemolytic Uremic Syndrome]]<span name="harr_c115s002s002s002p001"></span><span name="9100796"></span> | | colspan="2" |[[Hemolytic-uremic syndrome|Hemolytic Uremic Syndrome]]<span name="harr_c115s002s002s002p001"></span><span name="9100796"></span> | ||
|History of: | |History of: | ||
* Infections | * Infections | ||
Line 191: | Line 191: | ||
| | | | ||
|- | |- | ||
| colspan=" | | colspan="3" |Thromobcytosis<span name="harr_c115s002s003p001"></span><span name="9100800"></span> | ||
| | | | ||
* Digital pain | * Digital pain | ||
Line 212: | Line 212: | ||
|- | |- | ||
| rowspan="5" |Qualitative Disorders of [[Platelet]] Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span> | | rowspan="5" |Qualitative Disorders of [[Platelet]] Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span> | ||
| rowspan=" | | rowspan="3" |Inherited Disorders of [[Platelet]] Function<span name="harr_c115s002s004s001p001"></span><span name="9100803"></span> | ||
|Glanzmann’s thrombasthenia | |Glanzmann’s thrombasthenia | ||
| | |||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 227: | Line 228: | ||
|- | |- | ||
|Bernard-Soulier syndrome | |Bernard-Soulier syndrome | ||
| | |||
| | | | ||
| | | | ||
Line 239: | Line 241: | ||
|AR inheritance/ absence of the platelet Gp Ib-IX-V receptor | |AR inheritance/ absence of the platelet Gp Ib-IX-V receptor | ||
|- | |- | ||
|Platelet storage pool disorder (SPD) | |||
| | | | ||
| | | | ||
| | | | ||
Line 254: | Line 256: | ||
|- | |- | ||
|Acquired Disorders of [[Platelet]] Function<span name="harr_c115s002s004s002p001"></span><span name="9100808"></span> | |Acquired Disorders of [[Platelet]] Function<span name="harr_c115s002s004s002p001"></span><span name="9100808"></span> | ||
| | |||
| | | | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
Line 268: | Line 271: | ||
|- | |- | ||
|[[Von Willebrand disease|Von Willebrand Disease]]<span name="harr_c115s002s005p001"></span><span name="9100810"></span> | |[[Von Willebrand disease|Von Willebrand Disease]]<span name="harr_c115s002s005p001"></span><span name="9100810"></span> | ||
| | |||
| | | | ||
* Easy bruising | * Easy bruising | ||
Line 289: | Line 293: | ||
| rowspan="2" |Vessel wall disorders | | rowspan="2" |Vessel wall disorders | ||
| colspan="2" |[[Metabolism|Metabolic]] and [[Inflammation|Inflammatory]] Disorders | | colspan="2" |[[Metabolism|Metabolic]] and [[Inflammation|Inflammatory]] Disorders | ||
| | |||
| | | | ||
| | | | ||
Line 303: | Line 308: | ||
|- | |- | ||
| colspan="2" |Inherited Disorders of the [[Vessel wall|Vessel Wall]] | | colspan="2" |Inherited Disorders of the [[Vessel wall|Vessel Wall]] | ||
| | |||
| | | | ||
| | | | ||
Line 318: | Line 324: | ||
| rowspan="12" |Coagulation factor disorders | | rowspan="12" |Coagulation factor disorders | ||
| colspan="2" |[[Fibrinogen]] deficiency | | colspan="2" |[[Fibrinogen]] deficiency | ||
| | |||
| | | | ||
* [[Epistaxis]] | * [[Epistaxis]] | ||
Line 344: | Line 351: | ||
|- | |- | ||
| colspan="2" |[[Prothrombin deficiency]] | | colspan="2" |[[Prothrombin deficiency]] | ||
| | |||
| | | | ||
* Easy [[bruising]] | * Easy [[bruising]] | ||
Line 366: | Line 374: | ||
|- | |- | ||
| colspan="2" rowspan="1" |[[Factor V deficiency]] | | colspan="2" rowspan="1" |[[Factor V deficiency]] | ||
| | |||
| | | | ||
* Excessive bruising with minor injuries | * Excessive bruising with minor injuries | ||
Line 386: | Line 395: | ||
|- | |- | ||
| colspan="2" rowspan="1" |[[Factor VII deficiency]] | | colspan="2" rowspan="1" |[[Factor VII deficiency]] | ||
| | |||
| | | | ||
* Easy [[Bruise|bruising]] | * Easy [[Bruise|bruising]] | ||
Line 406: | Line 416: | ||
|- | |- | ||
| colspan="2" rowspan="1" |[[Factor X deficiency]] | | colspan="2" rowspan="1" |[[Factor X deficiency]] | ||
| | |||
| | | | ||
* Prolonged bleeding following circumcision | * Prolonged bleeding following circumcision | ||
Line 431: | Line 442: | ||
|- | |- | ||
| colspan="2" rowspan="1" |[[Factor XII|Factor XII deficiency]] | | colspan="2" rowspan="1" |[[Factor XII|Factor XII deficiency]] | ||
| | |||
| | | | ||
* Majority,asymptomatic | * Majority,asymptomatic | ||
Line 448: | Line 460: | ||
|- | |- | ||
| colspan="2" |HK deficiency | | colspan="2" |HK deficiency | ||
| | |||
| | | | ||
| | | | ||
Line 462: | Line 475: | ||
|- | |- | ||
| colspan="2" rowspan="1" |[[Prekallikrein]] deficiency | | colspan="2" rowspan="1" |[[Prekallikrein]] deficiency | ||
| | |||
| | | | ||
| | | | ||
Line 476: | Line 490: | ||
|- | |- | ||
| colspan="2" rowspan="1" |[[Factor XIII deficiency]] | | colspan="2" rowspan="1" |[[Factor XIII deficiency]] | ||
| | |||
| | | | ||
| | | | ||
Line 491: | Line 506: | ||
| rowspan="3" |[[Hemophilia]] | | rowspan="3" |[[Hemophilia]] | ||
|Type A deficiency | |Type A deficiency | ||
| | |||
| | | | ||
* Eeasy bruising | * Eeasy bruising | ||
Line 511: | Line 527: | ||
|- | |- | ||
|Type B deficiency | |Type B deficiency | ||
| | |||
| | | | ||
* Neonatal bleeding | * Neonatal bleeding | ||
Line 529: | Line 546: | ||
|- | |- | ||
|Type C deficiency | |Type C deficiency | ||
| | |||
| | | | ||
* Family history of bleeding disorder, | * Family history of bleeding disorder, | ||
Line 546: | Line 564: | ||
| rowspan="4" |Rare diseases | | rowspan="4" |Rare diseases | ||
| colspan="2" |[[Disseminated intravascular coagulation|Disseminated Intravascular Coagulation]] | | colspan="2" |[[Disseminated intravascular coagulation|Disseminated Intravascular Coagulation]] | ||
| | |||
| | | | ||
* Trauma | * Trauma | ||
Line 567: | Line 586: | ||
|- | |- | ||
| colspan="2" |[[Vitamin K Deficiency]] | | colspan="2" |[[Vitamin K Deficiency]] | ||
| | |||
| | | | ||
* Bleeding after trauma | * Bleeding after trauma | ||
Line 590: | Line 610: | ||
|- | |- | ||
| colspan="2" |Coagulation Disorders Associated with [[Hepatic failure|Liver Failure]] | | colspan="2" |Coagulation Disorders Associated with [[Hepatic failure|Liver Failure]] | ||
| | |||
| | | | ||
| | | | ||
Line 604: | Line 625: | ||
|- | |- | ||
| colspan="2" |Acquired Inhibitors of Coagulation Factors | | colspan="2" |Acquired Inhibitors of Coagulation Factors | ||
| | |||
| | | | ||
| | | |
Revision as of 16:34, 10 September 2018
Bleeding diathesis main page |
|
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Mehrian Jafarizade, M.D [2], Nazia Fuad M.D.
Overview
Bleeding diathesis is unusual susceptibility to bleed due to hypo-coagulopathies. These diseases can occur due to a disorder of homeostasis, localized process (tissue injury), or medications. Bleeding diathesis can be resulted from vessel wall injury, platelet disorders, and coagulation factor disorders. Clinical manifestation of bleeding disorders can have a wide range of symptoms from asymptomatic to symptomatic massive and life threatening bleeding. Platelet disorders mostly have skin manifestations such as petechiae, and ecchymoses. In order to find the cause of hypo-coagulopathy; there are established laboratory tests, such as peripheral blood smear, platelet count and platelet function analysis, coagulation factor deficiencies and inhibitors, fibrinolysis tests (eg. D-dimer level), bleeding time, prothrombin time, activated partial thromboplastin time, thrombin time and reptilase time.
Homostasis
Hemostasis is the process of blood clot formation at the site of bleeding. This process has 4 main phases as below:
Platelet plug formation
Coagulation cascade
Antithrombotic control
Fibrinolysis
Classification
Disorders of hemostasis can be classified into two main categories: platelet disorders, and disorders of coagulation. Each category can be further classified as bellow:
Platelet disorders:
- Thrombocytopenia: platelet count less than 150,000 per mm3
- Thromobcytosis: platelet countcmore than 450,000 per mm3
- Qualitative Disorders of Platelet function such as Von Willebrand Disease, inherited or acquired functional disorders.
Coagulation disorders
- Vessel wall disorders: Endothelial cells are lining entire vessel walls all over the body. Endothelium is an active layer responsible for inflammatory responses, angiogenesis and blood cell interactions. Endothelial cells have a very important role in hemostasis and they are regulating blood fluidity by the balance of antithrombotic/prothrombotic and vasodilatory/vasoconstrictor effects.
- Metabolic and Inflammatory Disorders
- Inherited Disorders of the Vessel Wall
- Coagulation factor disorders:
- Fibrinogen deficiency
- Prothrombin deficiency
- Factor V deficiency
- Factor VII deficiency
- Factor X deficiency
- Factor XII deficiency
- HK deficiency
- Prekallikrein deficiency
- Factor XIII deficiency
- Hemophilia
- Disseminated Intravascular Coagulation
- Vitamin K Deficiency
- Coagulation Disorders Associated with Liver Failure
- Acquired Inhibitors of Coagulation Factors
Differential Diagnosis
Category | Sub-category | Diseases | History | Clinical manifestation | Laboratory testing | Comments | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Petechiae | Ecchymoses | Menorrhagia | Hematoma | Hemarthrosis | Platelet count | Bleeding time (BT) | Prothrombin time (PT) | Activated partial thromboplastin time (aPTT) | Thrombin time (TT) | ||||||
Platelet disorders | Thrombocytopenia | Infection-Induced Thrombocytopenia |
|
+ | + | + | + | + | ↓ | N | N | ||||
Medications-Induced Thrombocytopenia |
|
+ | + | + | + | + | ↓ | N | N | ||||||
Heparin-Induced Thrombocytopenia |
|
+ | + | + | + | + | ↓ | ||||||||
Immune Thrombocytopenic Purpura (ITP) |
|
+ | + | + | + | + | ↓ | ↑ | N | N | |||||
Inherited Thrombocytopenia |
|
+ | + | + | + | + | ↓ | ↑ | N | N | |||||
Thrombotic Thrombocytopenic Purpura (TTP) | History of:
|
+ | + | + | + | + | ↑ | ||||||||
Hemolytic Uremic Syndrome | History of:
|
+ | + | + | + | + | N | N | |||||||
Thromobcytosis |
|
− | − | − | + | + | ↑ | Normal or slightly prolonged | ɴ | ɴ | |||||
Qualitative Disorders of Platelet Function | Inherited Disorders of Platelet Function | Glanzmann’s thrombasthenia | + | + | + | + | + | AR inheritance/ absence of the platelet Gp IIb/IIIa receptor | |||||||
Bernard-Soulier syndrome | AR inheritance/ absence of the platelet Gp Ib-IX-V receptor | ||||||||||||||
Platelet storage pool disorder (SPD) | AD inheritance/ abnormalities of platelet granule formation | ||||||||||||||
Acquired Disorders of Platelet Function | + | + | + | + | + | ||||||||||
Von Willebrand Disease |
|
+ | + | + | + | + | ↑ | Ν | ↑ | ↑ | |||||
Vessel wall disorders | Metabolic and Inflammatory Disorders | ||||||||||||||
Inherited Disorders of the Vessel Wall | |||||||||||||||
Coagulation factor disorders | Fibrinogen deficiency |
|
_ | + | + | + | N | ↑ | ↑ | ↑ | ↑ | The severity of bleeding in patients with fibrinogen disorders can be mild or severe, with higher bleeding risk in those with afibrinogenemia or lower levels of functional fibrinogen. The age of onset is also variable, with earlier onset in those with more severe deficiency. | |||
Prothrombin deficiency |
|
+ | + | + | + | + | N | N | ↑ | ↑ | ↑ | ||||
Factor V deficiency |
|
_ | + | + | + | + | N | ↑ | ↑ | ↑ | N | The severity of bleeding is only partly related to the degree of factor V deficiency. Some patients with undetectable plasma levels of factor V experience only relatively mild bleeding. | |||
Factor VII deficiency |
|
+ | + | + | N | ↑ | N | Thrombosis occurs in inherited factor VII deficiency most cases are associated with the administration of factor VII replacement therapy | |||||||
Factor X deficiency |
|
+ | + | + | + | + | N | N | ↑ | ↑ | N | ||||
Factor XII deficiency |
|
_ | _ | _ | _ | _ | N | N | ↑ | ↑ | N | ||||
HK deficiency | |||||||||||||||
Prekallikrein deficiency | |||||||||||||||
Factor XIII deficiency | |||||||||||||||
Hemophilia | Type A deficiency |
|
_ | _ | + | + | + | Unaffected | Unaffected | Unaffected | Prolonged | N | |||
Type B deficiency |
|
_ | _ | + | + | + | Unaffected | N | N | ↑ | N | ||||
Type C deficiency |
|
_ | _ | + | Rare | Rare | N | N | N | ↑ | N | ||||
Rare diseases | Disseminated Intravascular Coagulation |
|
+ | + | _ | + | + | ↓ | ↑ | ↑ | ↑ | ||||
Vitamin K Deficiency |
|
+ | + | + | + | + | N | ↑ | ↑ | Normal or mildly prolonged | |||||
Coagulation Disorders Associated with Liver Failure | |||||||||||||||
Acquired Inhibitors of Coagulation Factors |
Type of VWD | Type of factor deficiency | Prevalence | Inheritance pattern | Clinical manifestations | VWF activity | RIPA | Factor VIII | Plt levels | ||
---|---|---|---|---|---|---|---|---|---|---|
Type 1 | Quantitative/ partial | |||||||||
Type 2 | 2A | |||||||||
2B | ||||||||||
2M | ||||||||||
2N | ||||||||||
Type 3 |